High Evidence
Research Overview
CagriSema Research for Prediabetes
An evidence-based overview of research examining CagriSema in the context of prediabetes. This page synthesizes findings from peer-reviewed literature.
Research Summary
REDEFINE-1 enrolled adults without type 2 diabetes and reported weight outcomes, but the cited primary report does not establish that CagriSema prevents progression from prediabetes to diabetes. Glycemic subgroup observations should not be treated as a prevention trial endpoint.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.